Browse by author
Lookup NU author(s): Dr Salman RazviORCiD,
Dr Bijayeswar Vaidya,
Dr Petros Perros,
Professor Simon PearceORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Block-replace and titration antithyroid drug regimens both give similar rates of medium- to long-term remission of hyperthyroid Graves' disease. Recent meta-analysis, however, has suggested that titration regimens may be preferable owing to a higher rate of adverse events seen in the block-replace arms of published comparative studies. This article critically re-evaluates the evidence upon which these meta-analyses were based. We suggest that there is little objective evidence that is pertinent to current clinical practice to separate block-replace from titration antithyroid drug regimens and that both remain satisfactory approaches to the medical management of hyperthyroid Graves' disease. © 2006 Society of the European Journal of Endocrinology.
Author(s): Razvi S, Vaidya B, Perros P, Pearce SHS
Publication type: Article
Publication status: Published
Journal: European Journal of Endocrinology
ISSN (print): 0804-4643
ISSN (electronic): 1479-683X
Publisher: BioScientifica Ltd.
PubMed id: 16728536
Altmetrics provided by Altmetric